Catalyst Biosciences is a biopharmaceutical company based in South San Francisco, CA, specializing in the development of novel therapies for hemophilia and other rare bleeding disorders.
The company focuses on utilizing its proprietary protease engineering platform to create next-generation coagulation factors that aim to improve the lives of patients with these conditions.
Generated from their business information